We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roche has announced that a Tamiflu (oseltamivir phosphate) supply chain is now fully operational in the U.S., with an annual production capacity of 80 million treatment courses.
German drugmaker Schering AG and UK-based AstraZeneca have formed an alliance to co-develop and jointly commercialize Schering's selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer.
Xenon Pharmaceuticals Inc., a privately held company engaged in developing novel small molecule therapies for select neurological, cardiovascular and metabolic diseases, announced that Takeda Research Investment, Inc. (TRI) has made a strategic equity investment of USD $5M in the Company.
Torrent Pharmaceuticals Ltd has launched Nexpro Fast (Immediate Release Esomeprazole), a Proton Pump Inhibitor (PPI), for the first time in India to treat peptic ulcers and GERD (Gastro Esophageal Reflux Disease).
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
The World Health Organization (WHO) confirmed 49 deaths out of 65 cases of avian influenza in Indonesia, the organization spokesperson in Jakarta said Thursday.
Abraxis Oncology announced that it has received Health Canada approval for ABRAXANE for the treatment of metastatic breast cancer, including previously untreated metastatic disease.
Ugandan HIV/AIDS activists have expressed outrage after learning that an estimated $500,000 worth of antiretroviral (ARV) drugs recently expired in government stores, according to the United Nations news network.